Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial
Conclusions:
Metronidazole and rifaximin were similarly effective treatments for CDI in pediatric patients with IBD.
Source: Inflammatory Bowel Diseases - Category: Gastroenterology Tags: Original Clinical Articles Source Type: research
More News: Children | Clinical Trials | Clostridium Difficile | Crohn's Disease | Eyes | Inflammatory Bowel Disease | Metronidazole | Pediatrics | Statistics | Study | Ulcerative Colitis | Xifaxan